CareDx, Inc. Files Definitive Proxy Statement (DEF 14A)

Ticker: CDNA · Form: DEF 14A · Filed: Apr 29, 2024 · CIK: 1217234

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, Executive Compensation, CareDx, Corporate Governance

TL;DR

<b>CareDx, Inc. has filed its Definitive Proxy Statement detailing executive compensation and corporate governance matters.</b>

AI Summary

CareDx, Inc. (CDNA) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. CareDx, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 29, 2024. The filing covers the period ending June 13, 2024. The company was formerly known as XDx, Inc. and Expression Diagnostics Inc. The filing includes details on executive compensation for the fiscal year ending December 31, 2023. Specific compensation data for Mr. Johnson and Dr. Seeto is detailed, including equity awards and their valuations.

Why It Matters

For investors and stakeholders tracking CareDx, Inc., this filing contains several important signals. This filing provides shareholders with crucial information regarding executive compensation packages, allowing them to make informed voting decisions on executive pay and other corporate matters. The DEF 14A filing is a standard requirement for public companies and offers transparency into the company's governance, director nominations, and shareholder proposals.

Risk Assessment

Risk Level: — CareDx, Inc. shows moderate risk based on this filing. The filing is a routine DEF 14A, providing standard disclosures without immediate financial or operational news.

Analyst Insight

Review the executive compensation details and any shareholder proposals to understand potential impacts on company strategy and shareholder alignment.

Executive Compensation

NameTitleTotal Compensation
Mr. JohnsonMember
Dr. SeetoMember

Key Numbers

Key Players & Entities

FAQ

When did CareDx, Inc. file this DEF 14A?

CareDx, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 29, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by CareDx, Inc. (CDNA).

Where can I read the original DEF 14A filing from CareDx, Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by CareDx, Inc..

What are the key takeaways from CareDx, Inc.'s DEF 14A?

CareDx, Inc. filed this DEF 14A on April 29, 2024. Key takeaways: CareDx, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 29, 2024.. The filing covers the period ending June 13, 2024.. The company was formerly known as XDx, Inc. and Expression Diagnostics Inc..

Is CareDx, Inc. a risky investment based on this filing?

Based on this DEF 14A, CareDx, Inc. presents a moderate-risk profile. The filing is a routine DEF 14A, providing standard disclosures without immediate financial or operational news.

What should investors do after reading CareDx, Inc.'s DEF 14A?

Review the executive compensation details and any shareholder proposals to understand potential impacts on company strategy and shareholder alignment. The overall sentiment from this filing is neutral.

How does CareDx, Inc. compare to its industry peers?

CareDx, Inc. operates in the medical laboratories sector, providing diagnostic solutions.

Are there regulatory concerns for CareDx, Inc.?

As a public company, CareDx, Inc. is subject to SEC regulations requiring the filing of proxy statements for shareholder meetings and votes.

Industry Context

CareDx, Inc. operates in the medical laboratories sector, providing diagnostic solutions.

Regulatory Implications

As a public company, CareDx, Inc. is subject to SEC regulations requiring the filing of proxy statements for shareholder meetings and votes.

What Investors Should Do

  1. Analyze the executive compensation structure and total compensation for key executives like Mr. Johnson and Dr. Seeto.
  2. Review any shareholder proposals and the company's recommendations to understand potential impacts on company policy or strategy.
  3. Examine the details of equity awards, vesting schedules, and performance metrics to assess alignment with shareholder interests.

Key Dates

Year-Over-Year Comparison

This is the initial filing of the DEF 14A for the current reporting cycle, providing forward-looking information for the upcoming shareholder meeting.

Filing Stats: 4,945 words · 20 min read · ~16 pages · Grade level 11.1 · Accepted 2024-04-29 16:19:02

Key Financial Figures

Filing Documents

Dilution

Dilution 41 Historical Burn Rate 41 Summary of the 2024 Plan 42 Form S-8 Registration Statement 48 New Plan Benefits 48 Federal Income Tax Consequences 49 Vote Required; Board Recommendation 51 EXECUTIVE OFFICERS 52 Legal Proceedings with Executive Officers 52

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 53 Compensation Discussion and Analysis 53 I. Executive Summary 53 II. Compensation Philosophy 55 III. Compensation Determination Process 56 IV. Pay Components 58 Compensation Committee Report 64 Summary Compensation Table 64 Grants of Plan-Based Awards 65 Outstanding Equity Awards at Fiscal Year-End 66 Option Exercises and Stock Vested 71 Pension Benefits 71 Pay Ratio Disclosure 73 Pay Versus Performance 74 Equity Compensation Plan Information 79

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 80 RELATED PARTY TRANSACTIONS 83 Indemnification Agreements 83 Rule 10b5-1 Sales Plans 83 Policies and Procedures for Related Party Transactions 83 OTHER MATTERS 84 Delinquent Section 16(a) Reports 84 Available Information 84 Note About Forward-Looking Statements 84 Householding 84 Company Website 85 APPENDIX A – 2024 Equity Incentive Plan A - 1 CAREDX, INC. PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held at 10:00 a.m. Pacific Time on Thursday, June 13, 2024 We sent you this proxy statement and the enclosed proxy card because the Board of Directors (" Board of Directors ") of CareDx, Inc. (sometimes referred to as " we ", " CareDx " or the " Company ") is soliciting your proxy to vote at the Company's 2024 annual meeting of stockholders (the " Annual Meeting ") and any postponements, adjournments or continuations thereof. The Annual Meeting will be held on Thursday, June 13, 2024 at 10:00 a.m. Pacific Time, virtually via live webcast at http://www.virtualshareholdermeeting.com/CDNA2024. You are invited to attend the Annual Meeting and we request that you vote on the proposals described in this proxy statement. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may complete, sign and return the enclosed proxy card or submit your proxy through the Internet or by telephone according to the instructions contained in the enclosed proxy card. The Notice of Internet Availability of Proxy Materials (the " Notice ") containing instructions on how to access this proxy statement and our annual report is first being mailed on or about April 29, 2024 to all stockholders entitled to receive notice of and to vote at the Annual Meeting. QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING The information provided in the "question and answer" format below addresses certain frequently asked questions but is not intended to be a s

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing